152 related articles for article (PubMed ID: 32641850)
1. The clinical cutting edge.
Nat Biotechnol; 2020 Jul; 38(7):767. PubMed ID: 32641850
[No Abstract] [Full Text] [Related]
2. CRISPR treatment inserted directly into the body for first time.
Ledford H
Nature; 2020 Mar; 579(7798):185. PubMed ID: 32157225
[No Abstract] [Full Text] [Related]
3. Recent Advances in Therapeutic Genome Editing in China.
Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
[TBL] [Abstract][Full Text] [Related]
4. The Future of CRISPR Applications in the Lab, the Clinic and Society.
Hough SH; Ajetunmobi A
Adv Exp Med Biol; 2017; 1016():157-178. PubMed ID: 29130159
[TBL] [Abstract][Full Text] [Related]
5. Writing the Story of Gene Editing and CRISPR: An Interview with Kevin Davies, PhD.
Flotte TR
Hum Gene Ther; 2020 Dec; 31(23-24):1217-1220. PubMed ID: 33337270
[No Abstract] [Full Text] [Related]
6. With First CRISPR Trials, Gene Editing Moves Toward the Clinic.
Hampton T
JAMA; 2020 Apr; 323(16):1537-1539. PubMed ID: 32267478
[No Abstract] [Full Text] [Related]
7. CRISPR-Cas9-mediated therapeutic editing of
Jo DH; Song DW; Cho CS; Kim UG; Lee KJ; Lee K; Park SW; Kim D; Kim JH; Kim JS; Kim S; Kim JH; Lee JM
Sci Adv; 2019 Oct; 5(10):eaax1210. PubMed ID: 31692906
[TBL] [Abstract][Full Text] [Related]
8. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
Carlson B
Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
[No Abstract] [Full Text] [Related]
9. First in vivo human genome editing trial.
Nat Biotechnol; 2018 Jan; 36(1):5. PubMed ID: 29319687
[No Abstract] [Full Text] [Related]
10. National Academies relax stance on germline edits.
Sheridan C
Nat Biotechnol; 2017 Apr; 35(4):295-296. PubMed ID: 28398320
[No Abstract] [Full Text] [Related]
11. Therapeutic Germline Editing: Sense and Sensibility.
Adashi EY; Cohen IG
Trends Genet; 2020 May; 36(5):315-317. PubMed ID: 31982142
[TBL] [Abstract][Full Text] [Related]
12. The Future of Genome Editing.
Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947
[TBL] [Abstract][Full Text] [Related]
13. Genome Surgery and Gene Therapy in Retinal Disorders.
Chan L; Mahajan VB; Tsang SH
Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
[TBL] [Abstract][Full Text] [Related]
14. Gene editing based hearing impairment research and therapeutics.
Kang W; Sun Z; Zhao X; Wang X; Tao Y; Wu H
Neurosci Lett; 2019 Sep; 709():134326. PubMed ID: 31195050
[TBL] [Abstract][Full Text] [Related]
15. How CRISPR gene editing could help treat Alzheimer's.
Thompson T
Nature; 2024 Jan; 625(7993):13-14. PubMed ID: 38082131
[No Abstract] [Full Text] [Related]
16. Human genome editing: ask whether, not how.
Hurlbut JB
Nature; 2019 Jan; 565(7738):135. PubMed ID: 30602779
[No Abstract] [Full Text] [Related]
17. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
Epstein BE; Schaffer DV
Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
[TBL] [Abstract][Full Text] [Related]
18. A CRISPR edit for heart disease.
King A
Nature; 2018 Mar; 555(7695):S23-S25. PubMed ID: 29517035
[No Abstract] [Full Text] [Related]
19. [The CRISPR-Cas system: beyond genome editing].
Croteau FR; Rousseau GM; Moineau S
Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
[TBL] [Abstract][Full Text] [Related]
20. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
